Latest Conference Articles

Tecfidera has been on the market for a few years to help treat relapsing remitting multiple sclerosis and through extended studies and watching the market positive results have been seen by patients using the oral treatment.

More than three-quarters of intravenous drug users and Baby Boomers tested for hepatitis C were positive and unaware they were infected, according to results of a study published in the journal Annals of Emergency Medicine.

Even as more medications are developed for relapsing remitting multiple sclerosis patients those with the primary progressive form have been left waiting for news on their condition. According to recent studies the first step in that process may soon be coming to the market.

With doctors having to take on more administrative work in addition to their patient care duties finding systems that can help them accomplish their goals without adding more time consuming tasks can be crucial.

Patients with early rheumatoid arthritis may have reduced myocardial and vascular function.

Researchers continue to look at the age-old question of when to stop treatment with antiplatelet drugs if surgery is necessary. Stopping them too soon increases risk of clotting. Stopping them too late increases risk of excessive blood loss.

Just in time for flu season, a California study shows that physicians are all too willing to work while they themselves are ill.

Newer medications for the treatment of multiple sclerosis have been developed in recent years but for some patients interferon remains the starting point for pharmaceutical options.

Just as overactive bladder issues and constipation are an issue for patients with multiple sclerosis, mirabegron is a popular medication in the general population for managing these issues. At the NYU Langone Medical Center Comprehensive Care Center patients receive treatment from a wide variety of healthcare professionals in order to get the best results possible for their condition.

As patients with multiple sclerosis get older memory loss becomes a growing problem. Ways to slow that process including digital technology to help keep a patient's brain sharp.

Respiratory viruses send patients of all ages to hospitals. A University of Massachusetts team analyzed exactly which viruses were most common and the degrees to which they made people ill.

Optic neuritis is linked to multiple sclerosis and a treatment to help patients with this condition continues to work its way through the research and approval process. Unlike other areas of multiple sclerosis treatment there is no singular way to measure or determine cognitive impairment in patients.

Air pollution affects liver health and can cause fibrosis, according to findings published in the Journal of Hepatology.

Though it is still in development, a blood test may be able to detect pancreatic cancer in early stages, according to a proof of concept study published in Cancer Prevention Research.

Having HIV puts patients co-infected with hepatitis C at far higher risk. A Baltimore team looked at using statins to slow the course of the liver disease.

Using "big data" a research team from the University of Chicago and other institutions found that where infectious disease training programs are more common, patients with HIV/AIDS do better.

Consults with infectious disease specialists improved outcomes for patients with SAB, a Canadian team reports.

Percutaneous liver biopsy is a proven way to rate the fibrosis stage both in hepatitis in chronic hepatitis C patients and hepatitis B patients. But it is uncomfortable for patients, risks complications and is prone to assembling errors. Reporting at ID Week 2015 in San Diego, CA, Tuma Demirdal, DR, and colleagues at the Katip Celebi University in Izmir, Turkey compared these invasive tests with non-invasive methods.

Infection with candida can be fatal. Reporting at ID Week 2015, a team from South Korea reported that C.tropicalis is the predominant cause of persistent infection.

Tea time was hazardous at a Tokyo pediatric hospital. In a cautionary tale for other hospitals, Kenta Ito, MD and colleagues reporting at ID Week 2015 in San Diego, CA, said researchers found carbapenem-resistant enterobacteriaceae (CRE) in a contaminated tea dispenser.

Eye banks are generally thought to be a safe place to get tissue for corneal transplant. But a New Hampshire team reporting at ID Week 2015 in San Diego, CA said they found two post-operative candida infections in corneal transplant recipients .

In ethnically diverse groups of hospital workers latent tuberculosis infection may need to be addressed. Exposure to Mycobacterium tuberculosis is higher in health care workers who were not born in the US. Reporting at ID Week 2015 in San Diego, Cal, researchers from Memorial Sloan Kettering Cancer Center said the hospital had more success with some treatment regimens for such workers than with others.

Although there was widespread circulation of influenza viruses that were antigenically drifted from the vaccine virus, last year's flu vaccine appears to have been effective in preventing severe illness requiring hospitalization.

Researchers have identified GS-5734 (a prodrug of adenine nucleotide analog) as an inhibitor of pathogenic filoviruses, such as the Ebola virus.

Test performs comparably to standard reverse-transcriptase polymerase chain reaction assays using whole blood and buccal swab specimens.

Study results show there are minimal drug-drug interactions between tenofovir alafenamide-based antiretroviral regimens for HIV and ledipasvir/sofosbuvir combination treatment for hepatitis C.

Treatment simplification maintains viral suppression and reduces proteinuria, potentially improving treatment adherence.

Treatment-experienced patients with HIV who switched to a tenofovir alafenamide-based treatment regimen maintained excellent virologic suppression while exhibiting significant improvements in both bone and renal safety.

IDWeek has become much more integrated and does an excellent job in helping specialists take their shared information to make their clinical practices better.

In 1992 the European Committee For Treatment And Research in Multiple Sclerosis met in Barcelona with 200 people in attendance. Twenty three years later the same conference was held in the same city with more than 9000 people in attendance and more than 1000 abstracts submitted.